At the nucleus of SCVI is a richly diverse group of 178 University
faculty scientists, scholars, engineers and adult and pediatric
clinicians whose multidisciplinary collaborations will focus on the
prevention, treatment, and ultimate elimination of cardiovascular diseases.
SCVI is one of four institutes established by Stanford School of
Medicine to be the pillars of its future interdisciplinary efforts in
understanding, preventing and treating human disease.
The Stanford Cardiovascular Institute will:
Develop and pioneer integrative strategies to prevent, treat
and ultimately cure heart disease
Advance the frontiers of
Translate the extraordinary
progress of science and technology into new applications
This unusual procedure, known as a "domino" transplant, occurs when one recipient receives a heart-lung transplant from a deceased donor, while the existing healthy heart of the heart-lung recipient is given to a second patient. The rare procedure has only been performed eight times at Stanford, last in 1994.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.